Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T43332 | Target Info | |||
Target Name | Coagulation factor VII (F7) | ||||
Synonyms | Serum prothrombin conversion accelerator; SPCA; Proconvertin; Eptacog alfa | ||||
Target Type | Successful Target | ||||
Gene Name | F7 | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | Ligand Info | |||
Canonical SMILES | C(C1C(C(C(C(O1)O)O)O)O)O | ||||
InChI | 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6+/m1/s1 | ||||
InChIKey | WQZGKKKJIJFFOK-DVKNGEFBSA-N | ||||
PubChem Compound ID | 79025 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 2C4F crystal structure of factor VII.stf complexed with pd0297121 | ||||||
Method | X-ray diffraction | Resolution | 1.72 Å | Mutation | No | [1] |
PDB Sequence |
FLLRPGSLRC
17 KQCSFARIFK32 DARTKLFWIS43 YSDGDQCASS53 PCQNGGSCKD63 QLQSYICFCL 73 PAFEGRNCET83 HKDDQLICVN93 ENGGCEQYCS103 DHTGTKRSCR113 CHEGYSLLAD 123 GVSCTPTVEY133 PCGKIPILE
|
|||||
|
||||||
PDB ID: 2A2Q Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+ | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [2] |
PDB Sequence |
ANAFLLRPGS
12 LRCKQCSFAR28 IFKDARTKLF40 WISYSDGDQC50 ASSPCQNGGS60 CKDQLQSYIC 70 FCLPAFEGRN80 CETHKDDQLI90 CVNENGGCEQ100 YCSDHTGTKR110 SCRCHEGYSL 120 LADGVSCTPT130 VEYPCGKIPI140 LE
|
|||||
|
||||||
PDB ID: 2AER Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. | ||||||
Method | X-ray diffraction | Resolution | 1.87 Å | Mutation | Yes | [2] |
PDB Sequence |
ANAFLLRPGS
12 LRCKQCSFAR28 IFKDARTKLF40 WISYSDGDQC50 ASSPCQNGGS60 CKDQLQSYIC 70 FCLPAFEGRN80 CETHKDDQLI90 CVNENGGCEQ100 YCSDHTGTKR110 SCRCHEGYSL 120 LADGVSCTPT130 VEYPCGKIPI140 LE
|
|||||
|
||||||
PDB ID: 2FIR Crystal structure of DFPR-VIIa/sTF | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [2] |
PDB Sequence |
ANAFLLRPGS
12 LRCKQCSFAR28 IFKDARTKLF40 WISYSDGDQC50 ASSPCQNGGS60 CKDQLQSYIC 70 FCLPAFEGRN80 CETHKDDQLI90 CVNENGGCEQ100 YCSDHTGTKR110 SCRCHEGYSL 120 LADGVSCTPT130 VEYPCGKIPI140 LE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GLC or .GLC2 or .GLC3 or :3GLC;style chemicals stick;color identity;select .L:49 or .L:52 or .L:54 or .L:68; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 3ELA Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | Yes | [3] |
PDB Sequence |
DQCASSPCQN
57 GGSCKDQLQS67 YICFCLPAFE77 GRNCETHKDD87 QLICVNENGG97 CEQYCSDHTG 107 TKRSCRCHEG117 YSLLADGVSC127 TPTVEYPCGK137 IPILE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GLC or .GLC2 or .GLC3 or :3GLC;style chemicals stick;color identity;select .L:49 or .L:52 or .L:54 or .L:66 or .L:67 or .L:68; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 1QFK STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | No | [4] |
PDB Sequence |
QCASSPCQNG
58 GSCKDQLQSY68 ICFCLPAFEG78 RNCETHKDDQ88 LICVNENGGC98 EQYCSDHTGT 108 KRSCRCHEGY118 SLLADGVSCT128 PTVEYPCGKI138 PILEKR
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GLC or .GLC2 or .GLC3 or :3GLC;style chemicals stick;color identity;select .L:49 or .L:52 or .L:53 or .L:54 or .L:66 or .L:68; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 2B8O Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | No | [5] |
PDB Sequence |
ANAFLLRPGS
12 LRCKQCSFAR28 IFKDARTKLF40 WISYSDGDQC50 ASSPCQNGGS60 CKDQLQSYIC 70 FCLPAFEGRN80 CETHKDDQLI90 CVNENGGCEQ100 YCSDHTGTKR110 SCRCHEGYSL 120 LADGVSCTPT130 VEYPCGKIPI140 LE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GLC or .GLC2 or .GLC3 or :3GLC;style chemicals stick;color identity;select .L:49 or .L:52 or .L:54 or .L:68; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 1J9C Crystal Structure of tissue factor-factor VIIa complex | ||||||
Method | X-ray diffraction | Resolution | 2.90 Å | Mutation | No | [6] |
PDB Sequence |
DQCASSPCQN
57 GGSCKDQLQS67 YICFCLPAFE77 GRNCETHKDD87 QLICVNENGG97 CEQYCSDHTG 107 TKRSCRCHEG117 YSLLADGVSC127 TPTVEYPCGK137 IPILE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GLC or .GLC2 or .GLC3 or :3GLC;style chemicals stick;color identity;select .L:49 or .L:52 or .L:53 or .L:54 or .L:68; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 1FAK HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [7] |
PDB Sequence |
RTKLFWISYS
45 DGDQCASSPC55 QNGGSCKDQL65 QSYICFCLPA75 FEGRNCETHK85 DDQLICVNEN 95 GGCEQYCSDH105 TGTKRSCRCH115 EGYSLLADGV125 SCTPTVEYPC135 GKIPILEK |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GLC or .GLC2 or .GLC3 or :3GLC;style chemicals stick;color identity;select .L:49 or .L:52 or .L:53 or .L:54 or .L:68; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2. Bioorg Med Chem Lett. 2006 Feb 15;16(4):1060-4. | ||||
REF 2 | High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa. J Biol Chem. 2006 Aug 25;281(34):24873-88. | ||||
REF 3 | Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity. J Biol Chem. 2008 Sep 19;283(38):25863-70. | ||||
REF 4 | Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8925-30. | ||||
REF 5 | Crystal Structure of Factor VIIa/soluble Tissue Factor complexed with Glu-Gly-Arg-Chloromethyl ketone | ||||
REF 6 | Ligand Induced Conformational Transitions of Tissue Factor. Crystal Structure of the Tissue Factor:Factor VIIa Complex. | ||||
REF 7 | Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. J Mol Biol. 1999 Feb 5;285(5):2089-104. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.